Vitamin D in COPD - a pleiotropic micronutrient in a multisystem disease

Current Respiratory Medicine Reviews

Volumn 7, Issue 6, 2011, Pages 414-420

  Jackson, Abigail S ^a   Hopkinson, Nicholas S ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

COPD; Immune system; Lung function; Osteoporosis; Skeletal muscle; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CATHELICIDIN; PARATHYROID HORMONE; TRACE ELEMENT; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR;

ANTIBACTERIAL ACTIVITY; B LYMPHOCYTE; BODY MASS; BRONCHUS MUSCLE; CACHEXIA; CALCIUM ABSORPTION; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHEMOTAXIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DENDRITIC CELL; DIETARY INTAKE; ENERGY EXPENDITURE; ESCHERICHIA COLI; FIBROBLAST; FRAGILITY FRACTURE; GENETIC ASSOCIATION; HUMAN; IMMUNE SYSTEM; INNATE IMMUNITY; LUNG CANCER; LUNG DEVELOPMENT; LUNG FUNCTION; MACROPHAGE; MUSCLE FUNCTION; MUSCULOSKELETAL FUNCTION; MYCOBACTERIUM TUBERCULOSIS; NEOPLASM; NEUTROPHIL; NONHUMAN; OBESITY; OSTEOPENIA; OSTEOPOROSIS; PLEIOTROPY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; REVIEW; SKELETAL MUSCLE; SMOOTH MUSCLE FIBER; TH1 CELL; TH2 CELL; UNDERWEIGHT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

EID: 81155150914     PISSN: 1573398X     EISSN: 18756387     Source Type: Journal    
DOI: 10.2174/157339811798072612     Document Type: Review

References (107)

1. Nacul L, Soljak M, Samarasundera E, et al. COPD in England: a comparison of expected, model-based prevalence and observed prevalence from general practice data. J Public Health 2010: 2011; 33(1): 108-116.
2. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med 1998; 4(11): 1241-1243.
3. Graat-Verboom L, Wouters EF, Smeenk FW, et al. Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J 2009; 34(1): 209-218.
4. Seymour JM, Spruit MA, Hopkinson NS, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J 2010; 36(1):81-88.
5. Schols AM, Broekhuizen R, Weling-Scheepers CA, et al. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005; 82(1): 53-59.
6. Swallow EB, Reyes D, Hopkinson NS, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007; 62(2): 115-120.
7. Garcia-Rio F, Miravitlles M, Soriano JB, et al. Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir Res 2010; 11(1): 63.
8. Anzueto A, Leimer I, Kesten S. Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chron Obstruct Pulmon Dis 2009; 4: 245-251.
9. Hopkinson NS, Tennant RC, Dayer MJ, et al. A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res 2007; 8(1): 25.
10. Garcia Rodriguez LA, Wallander MA, Martin-Merino E, Johansson S. Heart failure, myocardial infarction, lung cancer and death in COPD patients: A UK primary care study. Respir Med 2010; 104(11): 1691-1699.
11. Finkelstein J, Cha E, Scharf SM. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis 2009; 4: 337-349.
12. Nykjaer A, Fyfe JC, Kozyraki R, et al. Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3). Proc Natl Acad Sci USA 2001; 98(24): 13895-13900.
13. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008; 29(6): 726-776.
14. Janssens W, Lehouck A, Carremans C, et al. Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. Am J Respir Crit Care Med 2009; 179(8): 630-636.
15. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357(3): 266-281.
16. Hypponen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007; 85(3): 860-868.
17. Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporos Int 2005; 16(7): 713-716.
18. Lauridsen AL, Vestergaard P, Hermann AP, et al. Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxyvitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int 2005; 77(1): 15-22.
19. Taes YE, Goemaere S, Huang G, et al. Vitamin D binding protein, bone status and body composition in community-dwelling elderly men. Bone 2006; 38(5): 701-707.
20. Ahn J, Yu K, Stolzenberg-Solomon R, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 2010; 19(13): 2739-2745.
21. Webb AR, Engelsen O. Calculated ultraviolet exposure levels for a healthy vitamin D status. Photochem Photobiol 2006; 82(6): 1697-1703.
22. Pitta F, Troosters T, Spruit MA, et al. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171(9): 972-977.
23. Baghai-Ravary R, Quint JK, Goldring JJ, et al. Determinants and impact of fatigue in patients with chronic obstructive pulmonary disease. Respir Med 2009; 103(2): 216-223.
24. Donaldson GC, Wilkinson TM, Hurst JR, et al. Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171(5): 446-452.
25. de Batlle J, Romieu I, Anto JM, et al. Dietary habits of firstly admitted Spanish COPD patients. Respir Med 2009; 103(12): 1904-1910.
26. Janssens W, Bouillon R, Claes B, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010; 65(3): 215-220.
27. Forli L, Bjortuft O, Boe J. Vitamin D status in relation to nutritional depletion and muscle function in patients with advanced pulmonary disease. Exp Lung Res 2009; 35(6): 524-538.
28. Brock KE, Graubard BI, Fraser DR, et al. Predictors of vitamin D biochemical status in a large sample of middle-aged male smokers in Finland. Eur J Clin Nutr 2010; 64(3): 280-288.
29. Vilarrasa N, Maravall J, Estepa A, et al. Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables. J Endocrinol Invest 2007; 30(8): 653-658.
30. Moschonis G, Tanagra S, Koutsikas K, et al. Association between serum 25-hydroxyvitamin D levels and body composition in postmenopausal women: the postmenopausal Health Study. Menopause 2009; 16(4): 701-707.
31. Gomez JM, Maravall FJ, Gomez N, et al. Relationship between 25- (OH) D3, the IGF-I system, leptin, anthropometric and body composition variables in a healthy, randomly selected population. Horm Metab Res 2004; 36(1): 48-53.
32. Schellenberg D, Pare PD, Weir TD, et al. Vitamin D binding protein variants and the risk of COPD. Am J Respir Crit Care Med. 1998; 157(3 Pt 1): 957-961.
33. Ishii T, Keicho N, Teramoto S, et al. Association of Gc-globulin variation with susceptibility to COPD and diffuse panbronchiolitis. Eur Respir J 2001; 18(5): 753-757.
34. Ito I, Nagai S, Hoshino Y, et al. Risk and severity of COPD is associated with the group-specific component of serum globulin 1F allele. Chest 2004; 125(1): 63-70.
35. Wilk JB, Walter RE, Laramie JM, et al. Framingham Heart Study genome-wide association: results for pulmonary function measures. BMC Med Genet 2007; 8 Suppl 1: S8.
36. Bakke PS, Zhu G, Gulsvik A, et al. Candidate genes for chronic obstructive pulmonary disease in two large data sets. Eur Respir J 2011; 37(2): 255-263.
37. Ramos-Lopez E, Jansen T, Ivaskevicius V, et al. Protection from type 1 diabetes by vitamin D receptor haplotypes. Ann N Y Acad Sci 2006; 1079: 327-334.
38. Ogunkolade BW, Boucher BJ, Prahl JM, et al. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 2002; 51(7): 2294-2300.
39. Engelman CD, Fingerlin TE, Langefeld CD, et al. Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25- dihydroxyvitamin D levels in Hispanic and African Americans. J Clin Endocrinol Metab 2008; 93(9): 3381-3388.
40. Black PN, Scragg R. Relationship between serum 25- hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest 2005; 128(6): 3792-3798.
41. Djekic UV, Gaggar A, Weathington NM. Attacking the multitiered proteolytic pathology of COPD: new insights from basic and translational studies. Pharmacol Ther 2009; 121(2): 132-146.
42. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2(1): 50-60.
43. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009; 360(23): 2445-2454.
44. Shi W, Chen F, Cardoso WV. Mechanisms of lung development: contribution to adult lung disease and relevance to chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009; 6(7): 558-563.
45. Bosse Y, Maghni K, Hudson TJ. 1alpha,25-dihydroxy-vitamin D3 stimulation of bronchial smooth muscle cells induces autocrine, contractility, and remodeling processes. Physiol Genomics 2007; 29(2): 161-168.
46. Ramirez AM, Wongtrakool C, Welch T, et al. Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cells. J Steroid Biochem Mol Biol 2010; 118(3): 142-150.
47. Hansdottir S, Monick MM, Hinde SL, et al. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol 2008; 181(10): 7090-7099.
48. Yokomura K, Suda T, Sasaki S, et al. Increased expression of the 25-hydroxyvitamin D(3)-1alpha-hydroxylase gene in alveolar macrophages of patients with lung cancer. J Clin Endocrinol Metab 2003; 88(12): 5704-5709.
49. Koli K, Keski-Oja J. 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ 2000; 11(4): 221-229.
50. Rehan VK, Torday JS, Peleg S, et al. 1Alpha,25-dihydroxy-3-epivitamin D3, a natural metabolite of 1alpha,25-dihydroxy vitamin D3: production and biological activity studies in pulmonary alveolar type II cells. Mol Genet Metab 2002; 76(1): 46-56.
51. Ormerod AK, Xing Z, Pedigo NG, et al. The calcitriol analogue EB1089 impairs alveolarization and induces localized regions of increased fibroblast density in neonatal rat lung. Exp Lung Res 2008; 34(4): 155-182.
52. Baeke F, Takiishi T, Korf H, et al. Vitamin D: modulator of the immune system. Curr Opin Pharmacol 2010; 10(4): 482-496.
53. Hiemstra PS. The role of epithelial beta-defensins and cathelicidins in host defense of the lung. Exp Lung Res 2007; 33(10): 537-542.
54. Bals R, Wang X, Zasloff M, et al. The peptide antibiotic LL- 37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci USA 1998; 95(16): 9541-9546.
55. Wang TT, Nestel FP, Bourdeau V, et al. Cutting edge: 1,25- dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004; 173(5): 2909-2912.
56. Martineau AR, Wilkinson KA, Newton SM, et al. IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol 2007; 178(11): 7190-7198.
57. Golec M, Reichel C, Mackiewicz B, et al. Cathelicidin LL-37, granzymes, TGF-beta1 and cytokines levels in induced sputum from farmers with and without COPD. Ann Agric Environ Med 2009; 16(2): 289-297.
58. Xiao W, Hsu YP, Ishizaka A, et al. Sputum cathelicidin, urokinase plasminogen activation system components, and cytokines discriminate cystic fibrosis, COPD, and asthma inflammation. Chest 2005; 128(4): 2316-2326.
59. Alroy I, Towers TL, Freedman LP. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 1995; 15(10): 5789-5799.
60. Boonstra A, Barrat FJ, Crain C, et al. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 2001; 167(9): 4974-4980.
61. Jeffery LE, Burke F, Mura M, et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 2009; 183(9): 5458-5467.
62. Barcelo B, Pons J, Ferrer JM, et al. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory Tlymphocyte response to tobacco smoking. Eur Respir J 2008; 31(3): 555-562.
63. Jaffar Z, Ferrini ME, Girtsman TA, et al. Antigen-specific Treg regulate Th17-mediated lung neutrophilic inflammation, B-cell recruitment and polymeric IgA and IgM levels in the airways. Eur J Immunol 2009; 39(12): 3307-3314.
64. Seemungal TA, Donaldson GC, Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161(5): 1608-1613.
65. Papi A, Bellettato CM, Braccioni F, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006; 173(10): 1114-1121.
66. Ginde AA, Mansbach JM, Camargo CA, Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009; 169(4): 384-390.
67. White JH. Vitamin D as an inducer of cathelicidin antimicrobial peptide expression: Past, present and future. J Steroid Biochem Mol Biol 2010; 121(1/2): 234-238
68. Chun RF, Lauridsen AL, Suon L, et al. Vitamin D-Binding Protein Directs Monocyte Responses to 25-Hydroxy- and 1,25-Dihydroxyvitamin D. J Clin Endocrinol Metab 2010; J Clin Endocrinol Metab 2010; 95(7): 3368-3376.
69. Chishimba L, Thickett DR, Stockley RA, et al. The vitamin D axis in the lung: a key role for vitamin D-binding protein. Thorax 2010; 65(5): 456-462.
70. Urashima M, Segawa T, Okazaki M, et al. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010; 91(5): 1255-1260.
71. Kherad O, Kaiser L, Bridevaux PO, et al. Upper viral respiratory infection, biomarkers and chronic obstructive pulmonary disease (COPD) exacerbations. Chest 2010; 138(4): 896-904
72. Suda T, Ueno Y, Fujii K, et al. Vitamin D and bone. J Cell Biochem 2003; 88(2): 259-266.
73. Chapuy MC, Pamphile R, Paris E, et al. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 2002; 13(3): 257-264.
74. Boonen S, Lips P, Bouillon R, et al. Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 2007; 92(4): 1415-1423.
75. Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ 2010; 340: b5463.
76. Aris RM, Neuringer IP, Weiner MA, et al. Severe osteoporosis before and after lung transplantation. Chest 1996; 109(5): 1176-1183.
77. Katsura H, Kida K. A comparison of bone mineral density in elderly female patients with COPD and bronchial asthma. Chest 2002; 122(6): 1949-1955.
78. Tschopp O, Boehler A, Speich R, et al. Osteoporosis before lung transplantation: association with low body mass index, but not with underlying disease. Am J Transplant 2002; 2(2): 167-172.
79. Scanlon PD, Connett JE, Wise RA, et al. Loss of bone density with inhaled triamcinolone in Lung Health Study II. Am J Respir Crit Care Med 2004; 170(12): 1302-1309.
80. Kjensli A, Mowinckel P, Ryg MS, et al. Low bone mineral density is related to severity of chronic obstructive pulmonary disease. Bone 2007; 40(2): 493-497.
81. Vrieze A, de Greef MH, Wijkstra PJ, et al. Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteoporos Int 2007; 18(9): 1197-1202.
82. Schlaich C, Minne HW, Bruckner T, et al. Reduced pulmonary function in patients with spinal osteoporotic fractures. Osteoporos Int 1998; 8(3): 261-267.
83. Leech JA, Dulberg C, Kellie S, et al. Relationship of lung function to severity of osteoporosis in women. Am Rev Respir Dis 1990; 141(1): 68-71.
84. Franco CB, Paz-Filho G, Gomes PE, et al. Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos Int 2009; 20(11): 1881-1887.
85. Yoshikawa S, Nakamura T, Tanabe H, et al. Osteomalacic myopathy. Endocrinol Jpn 1979; 26(Suppl): 65-72.
86. Boland R, de Boland AR, Marinissen MJ, et al. Avian muscle cells as targets for the secosteroid hormone 1,25-dihydroxy-vitamin D3. Mol Cell Endocrinol 1995; 114(1-2): 1-8.
87. Bischoff-Ferrari HA, Borchers M, Gudat F, et al. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res 2004; 19(2): 265-269.
88. Endo I, Inoue D, Mitsui T, et al. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 2003; 144(12): 5138-5144.
89. Boland R. Role of vitamin D in skeletal muscle function. Endocr Rev 1986; 7(4): 434-448.
90. Dhesi JK, Bearne LM, Moniz C, et al. Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status. J Bone Miner Res 2002; 17(5): 891-897.
91. Stewart JW, Alekel DL, Ritland LM, et al. Serum 25- hydroxyvitamin D is related to indicators of overall physical fitness in healthy postmenopausal women. Menopause 2009; 16(6): 1093-1101.
92. Zamboni M, Zoico E, Tosoni P, et al. Relation between vitamin D, physical performance, and disability in elderly persons. J Gerontol A Biol Sci Med Sci 2002; 57(1): M7-M11.
93. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of Vitamin D on falls: a meta-analysis. Jama 2004; 291(16): 1999-2006.
94. Sato Y, Iwamoto J, Kanoko T, et al. Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc Dis 2005; 20(3): 187-192.
95. Sorensen OH, Lund B, Saltin B, et al. Myopathy in bone loss of ageing: improvement by treatment with 1 alphahydroxycholecalciferol and calcium. Clin Sci (Lond) 1979; 56(2): 157-161.
96. Seymour JM, Moore L, Jolley CJ, et al. Outpatient pulmonary rehabilitation following acute exacerbations of COPD. Thorax 2010; 65(5): 423-428.
97. Jackson A, Hopkinson NS. Skeletal Muscle in Chronic Obstructive Pulmonary Disease. Clin Pulmonary Med 2009; 16(2): 61-67.
98. Roth SM, Zmuda JM, Cauley JA, et al. Vitamin D receptor genotype is associated with fat-free mass and sarcopenia in elderly men. J Gerontol A Biol Sci Med Sci 2004; 59(1): 10-15.
99. van Etten E, Verlinden L, Giulietti A, et al. The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur J Immunol 2007; 37(2): 395-405.
100. Goltzman D. Vitamin D action: Lessons learned from genetic mouse models. Ann N Y Acad Sci 2010; 1192(1): 145-152.
101. Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 2008; 52(5): 828-832.
102. Kendrick J, Targher G, Smits G, et al. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 2009; 205(1): 255-260.
103. Pfeifer M, Begerow B, Minne HW, et al. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001; 86(4): 1633-1667.
104. Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 2005; 16(2): 83-95.
105. Dogan I, Onen HI, Yurdakul AS, et al. Polymorphisms in the vitamin D receptor gene and risk of lung cancer. Med Sci Monit 2009; 15(8): BR232-BR242.
106. Nakagawa K, Kawaura A, Kato S, et al. Metastatic growth of lung cancer cells is extremely reduced in Vitamin D receptor knockout mice. J Steroid Biochem Mol Biol 2004; 89-90(1/5): 545-547.
107. Kilkkinen A, Knekt P, Heliovaara M, et al. Vitamin D status and the risk of lung cancer: a cohort study in Finland. Cancer Epidemiol Biomarkers Prev 2008; 17(11): 3274-3278.